Follow
Jason H. Rogers
Jason H. Rogers
Verified email at bcm.edu
Title
Cited by
Cited by
Year
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
RE Rau, BA Rodriguez, M Luo, M Jeong, A Rosen, JH Rogers, ...
Blood, The Journal of the American Society of Hematology 128 (7), 971-981, 2016
1302016
MIR-23A microRNA cluster inhibits B-cell development
KY Kong, KS Owens, JH Rogers, J Mullenix, CS Velu, HL Grimes, R Dahl
Experimental hematology 38 (8), 629-640. e1, 2010
1282010
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status
GJ Roboz, F Ravandi, AH Wei, H Dombret, F Thol, MT Voso, AC Schuh, ...
Blood, The Journal of the American Society of Hematology 139 (14), 2145-2155, 2022
502022
AML and the art of remission maintenance
M de Lima, GJ Roboz, U Platzbecker, C Craddock, G Ossenkoppele
Blood Reviews 49, 100829, 2021
202021
Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia
AT Fathi, EM Stein, CD DiNardo, MJ Levis, P Montesinos, S de Botton
American journal of hematology 96 (6), 735-746, 2021
202021
Oral azacitidine (CC-486) for the treatment of myeloid malignancies
G Garcia-Manero, H Döhner, AH Wei, I La Torre, B Skikne, CL Beach, ...
Clinical Lymphoma Myeloma and Leukemia 22 (4), 236-250, 2022
172022
E2A antagonizes PU. 1 activity through inhibition of DNA binding
JH Rogers, KS Owens, J Kurkewich, N Klopfenstein, SR Iyer, MC Simon, ...
BioMed Research International 2016 (1), 3983686, 2016
122016
Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4
KY Kong, EA Williamson, JH Rogers, T Tran, R Hromas, R Dahl
Blood, The Journal of the American Society of Hematology 114 (1), 60-63, 2009
122009
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities
JH Rogers, R Gupta, JM Reyes, MC Gundry, G Medrano, A Guzman, ...
Blood Advances 5 (19), 3876-3890, 2021
112021
A comprehensive diagnostic offering workflow increases the rate of actionable results of the 23-and 35-gene expression profile tests for use as ancillary diagnostic tools for …
M Goldberg, J Siegel, B Russell, J Rogers, K Covington, K Oelschlanger, ...
SKIN The Journal of Cutaneous Medicine 5 (6), s79-s79, 2021
32021
Oral mucosa harbors a high frequency of endothelial cells: a novel postnatal cell source for angiogenic regeneration
J Zhou, JH Rogers, SH Lee, DM Sun, H Yao, JJ Mao, KY Kong
Stem Cells and Development 26 (2), 91-101, 2017
32017
A Physician’s Guide to the Use of Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms
E Marks, A Jarell, J Ludzik, AS Farberg, HS Rabinovitz, RG Phelps, ...
The Journal of Clinical and Aesthetic Dermatology 16 (4), 12, 2023
22023
Precise modeling of IKZF1 alterations in human B-cell acute lymphoblastic leukemia cell lines reveals distinct chemosensitivity, homing, and engraftment properties
JH Rogers, R Gupta, JM Reyes, L Brunetti, MC Gundry, T Song, ...
Blood 132, 549, 2018
22018
The American Boeing and the European Airbus: Competition for aviation technology and markets. A comprehensive analysis
J Rogers
Rochester Institute of Technology, 2006
22006
Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling
BK Williams Jr, JJ Siegel, KM Alsina, L Johnston, A Sisco, K LiPira, ...
Melanoma Management 9 (3), MMT62, 2022
12022
Targeting signaling pathways vulnerabilities for the treatment of IKZF1-deleted ph-negative B lymphoblastic leukemia.
R Gupta, JH Rogers, X Long, R Aguilar, G Medrano, J Reyes, M Redell, ...
Journal of Clinical Oncology 40 (16_suppl), 7033-7033, 2022
12022
Targeting activated signaling pathways for the treatment of IKZF1-deleted B lymphoblastic leukemia
R Gupta, JH Rogers, X Long, G Medrano, JM Reyes, M Redell, ZT Ball, ...
Blood 134, 3789, 2019
12019
REMARKS ON COTTAM'S SPRING-BED, AND ON THE PREVENTION OF BED-SORES.
JH Rogers
The Lancet 54 (1372), 633-634, 1849
11849
Dose-dependent effects of Dnmt3a in an inducible murine model of KrasG12D-driven leukemia
JH Rogers, A Rosen, JM Reyes, S Ketkar, SE Conneely, R Gupta, L Yang, ...
Experimental Hematology, 104248, 2024
2024
The impact of surface orientation on surface roughness and fatigue life of laser-based powder bed fusion Ti-6Al-4V
J Rogers, J Elambasseril, C Wallbrink, B Krieg, M Qian, M Brandt, M Leary
Additive Manufacturing 85, 104149, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20